VJOncology Podcast
The Video Journal of Oncology (VJOncology) podcast covers the latest solid oncology news from international experts, including breast, lung, skin, genitourinary, head and neck, gynecological and more. Made for healthcare professionals and researchers, it is a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion.
Episodes
Immunotherapy updates in head and neck cancer from ASCO 2026
On this week’s episode of VJOncology podcasts, we bring you head and neck cancer highlights in immuno-oncology from the 2026 ASCO Annual Conference. Join Barbara Burtness from the Yale School of Medicine, Hannah Kenny from Thomas Jefferson University Hospital, Ari Rosenberg from the University of Chicago, Nabil Saba from Emory University, and Kedar Kirtane from Moffitt Cancer Center as they discus
Updates in skin cancer from ASCO 2026
In this week’s VJOncology podcast, we explore the latest advances in skin cancer from ASCO 2025, with a focus on melanoma and emerging cellular therapies. Join Alexandra Haugh of Massachusetts General Hospital Cancer Center, Boston, MA, Kalijn Bol of Radboud University Medical Center, Nijmegen, Netherlands, Allison Betof Warner of Stanford University, Stanford, CA, Omid Hamid of The Angeles Clinic
iwCAR-T 2026: advances in TIL therapy for solid tumors
Welcome to another episode of VJOncology Podcast, featuring a roundtable discussion from iwCAR-T 2026, which took place in Tampa, FL. This week, our experts explore advances in tumor-infiltrating lymphocyte (TIL) therapy for solid tumors. Join Benjamin Creelan from Moffitt Cancer Center, Rodabe Amaria from the University of Texas MD Anderson Cancer Center, Daniel Olson from the University of Chica
Beyond the algorithm: trust, evidence and equity in AI-enabled cancer care
In this week’s VJOncology podcast, we explore the latest developments in artificial intelligence (AI) in oncology and their potential to transform cancer care. Join Eleonora Teplinsky, Valley Health System, Paramus, NJ, Gil Shamai, Technion–Israel Institute of Technology, Haifa, Israel, Matthew Kurian, St. Elizabeth Healthcare, Edgewood, KY, Jai Patel, Atrium Health Wake Forest Baptist Comprehensi
GU cancer highlights from ASCO 2026
In this week’s VJOncology podcast, we present highlights in genitourinary cancer from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Join Andrew Armstrong of Duke University Medical Center, Srikala Sridhar of the Princess Margaret Cancer Centre, Tian Zhang of UT Southwestern Medical Center, and Lucia Nappi of the University of British Columbia as they discuss
Top updates from the ESMO Gastrointestinal Cancers Congress 2026
In this week’s VJOncology podcast, we had the opportunity to attend the 2026 ESMO Gastrointestinal Cancers Congress in Munich, Germany, where we explored the latest advances across gastrointestinal malignancies. Join Teresa Macarulla, Vall d’Hebron University Hospital, Barcelona, Spain, Giulia Martini, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy, Lorenza Rimassa, Hunimed
Highlights in lung cancer from ASCO 2026: LIBRETTO-432, CROWN, and more
This week, VJOncology brings you lung cancer highlights from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Join Alessandro di Federico from the Memorial Sloan Kettering Cancer Center, Erika Ruiz-Garcia of the Instituto Nacional de Cancerologia, Nandini Menon of the Tate Memorial Centre and Bjorn Henning Gronberg of the Norwegian University of Science and Technolo
Breast cancer highlights from ASCO 2026
For this week’s VJOncology podcast, we bring you highlights in breast cancer
from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in
Chicago, IL. Join Oleg Gluz of Evang. Krakenhaus “Bethesda” Klinik, Jana de
Boniface of the Karolinska Institutet, Peter Schmid of Queen Mary University of
London and Erika Hamilton of the Sarah Cannon Research Institute as they
discuss key trial
Gastrointestinal cancer updates at ASCO 2026: RASolute 302, EMERALD-3, and more
In this week’s VJOncology podcast, we had the opportunity to attend the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL, where we explored the latest advances in gastrointestinal (GI) cancers. Join Ghassan Abou-Alfa and Yelena Janjigian of Memorial Sloan Kettering Cancer Center, Scott Kopetz of The University of Texas MD Anderson Cancer Center, and Choong-Kun Lee of Yonsei
Highlights from ASCO 2026
In this episode of VJOncology podcasts, we present highlights from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Five leading experts share key data and insights spanning prostate cancer, sarcoma, lung cancer, colorectal cancer, and breast cancer. Dr Mary-Ellen Taplin from Dana-Farber Cancer Institute presents final analysis data from the PROTEUS trial, demon
iwCAR-T 2026: CARs targeting cell surface proteins
In this roundtable discussion from iwCAR-T 2026, a panel of experts in cell therapy for solid tumours discuss the current state of CAR T-cell therapy beyond hematological malignancies. The panel explores key challenges including target selection, T-cell persistence, and the immunosuppressive tumour microenvironment, alongside emerging strategies such as armoured CARs, combination approaches with t
Bladder Cancer Awareness Month: subtypes, diagnostics & breakthroughs
In this week’s VJOncology podcast, we mark Bladder Cancer Awareness Month by exploring recent advances in bladder cancer research and clinical care. Join Joaquim Bellmunt of Dana-Farber Cancer Institute, Boston, MA, Eva Compérat of Medical University of Vienna, Vienna, Austria, Roberto Contieri of Humanitas University, Milan, Italy, and Vadim Koshkin of University of California, San Francisco, CA,
Oncology highlights from AACR 2026
In this week’s VJOncology podcast, we bring you key updates from the 2026 AACR meeting across early-phase immuno-oncology and targeted therapy. Join leading experts Bruno Bockorny, Beth Israel Deaconess Medical Center, Boston, MA, Byoung Chul Cho, Yonsei University, Seoul, South Korea, Kristen Pauken, and Timothy Yap, MD Anderson Cancer Center, Houston, TX, as they discuss the clinical challenges
Beyond EGFR: navigating molecular targets and emerging therapies in advanced NSCLC
In this week's instalment of the VJOncology podcast, we examine the rapidly evolving treatment landscape of advanced non-small cell lung cancer, drawing on expert insights from ELCC 2026. This episode spans the breadth of precision oncology in NSCLC: from the clinical challenges of rare actionable alterations and emerging targeted agents, to the growing complexity of first-line treatment sequencin
Head and neck cancer awareness month: key trials and evolving treatment strategies
In this week’s VJOncology podcast, we mark Head and Neck Cancer Awareness Month by exploring recent advances in head and neck cancer. Join Kevin Harrington, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK, Takeshi Kodaira, Aichi Cancer Center, Nagoya, Japan, Andreas Dietz, University Hospital of Leipzig, Leipzig, Germany, and Nabil Saba, Emory University, At
Lung cancer highlights from the 24th BTOG annual conference
In this week’s VJOncology podcast, we had the opportunity to attend the 2026 British Thoracic Oncology Group (BTOG) conference, where we explored key developments in lung cancer screening, diagnostics, and clinical research. Join Robert Rintoul, University of Cambridge, Cambridge, UK, Lauren Dixon, London School of Hygiene & Tropical Medicine, London, UK, Mariana Brandao, Jules Bordet Institut
Immuno-oncology updates from 12th Immunotherapy of Cancer Conference
In this week’s VJOncology podcast, we had the opportunity to attend the 12th Immunotherapy of Cancer (ITOC) Conference, where we explored cutting-edge developments in cancer immunotherapy and tumor biology. Join David Giles of Washington University in St. Louis, MO, Bernard Fox of Providence Cancer Institute, Portland, OR, and Krijn Dijkstra of Netherlands Cancer Institute, Amsterdam, Netherlands
Top updates from ASCO GU 2026: latest trials in prostate, kidney, and bladder cancer
In this week’s VJOncology podcast, we will be covering highlights from ASCO GU 2026 in San Francisco, CA. Dive into the latest advancements in genitourinary cancers, including groundbreaking trial results and emerging treatment strategies. In this episode, join Enrique Gallardo, MD, Parc Taulí University Hospital, Barcelona, Spain, Jan-Jaap Mellema, MD, Netherlands Cancer Institute, Amsterdam, The
Esophageal cancer awareness month: from multidisciplinary dialogue to clinical impact
In this week’s VJOncology podcast, as part of Oesophageal Cancer Awareness Month in the UK, we are pleased to bring you the latest advances shaping the treatment landscape for oesophageal and gastroesophageal cancers. Join leading experts Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center, Berend van der Wilk, MD, Erasmus MC Cancer Institute, Kohei Shitara, MD, National Cancer Center Hos
ctDNA-guided surveillance and treatment monitoring in breast cancer
In this week’s VJOncology podcast, we are delighted to bring you the latest advances in circulating tumor DNA (ctDNA)-informed monitoring and follow-up strategies in breast cancer. Join leading experts Wolfgang Janni, MD, University of Ulm, Ulm, Germany, Arielle Medford, MD, Massachusetts General Cancer Center, Boston, MA, Seth Wander, MD, PhD, Massachusetts General Hospital, Boston, MA, and Rinat
What’s new in checkpoint inhibition? LAG-3/PD-1 bispecifics, ADC combos, and more
In this week’s VJOncology podcast, we bring you key updates on the evolving landscape of checkpoint inhibition beyond PD-1 and PD-L1 across solid tumors. Join leading experts Jesus Fuentes-Antras, MD, NEXT Oncology Madrid, Madrid, Spain, Laurence Buisseret, MD, PhD, Institute Jules Bordet, Brussels, Belgium, and Yuxiang Ma, MD, PhD, Sun Yat-Sen University Cancer Center, Guangzhou, China, as they d
Cervical cancer awareness month: advances in prevention and treatment
In recognition of Cervical Cancer Awareness Month, this episode of VJOncology podcasts explores advances in cervical cancer prevention and treatment. We hear from three leading experts who discuss pivotal developments shaping clinical practice. Dr Domenica Lorusso from Fondazione IRCCS National Cancer Institute of Milan examines the breakthrough combination of immunotherapy and radiotherapy in loc
Immunotherapy's expanding role in GI cancers: from 1L to adjuvant settings
This podcast is available on the GI Cancer Channel on VJOncology, an independent medical education platform, which is supported by Takeda (Gold) and Gilead Sciences (Silver). Supporters have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
This VJOncology podcast explores the evolving landscape of immunotherapy in gastroin
From biology to breakthroughs: new frontiers in head and neck cancer immunotherapy
In this week’s VJOncology podcast, we bring you key developments in novel approaches in immunotherapy refractory head and neck cancer. Join head and neck cancer expert Amanda Psyrri, MD, PhD, FACP, National Kapodistrian University of Athens, Athens, Greece, as she discusses on mechanisms of resistance to checkpoint inhibitors, strategies to overcome resistance such as antibody drug conjugates (ADC
How is AI transforming oncology care in 2026? From evidence to clinical practice
In this week’s VJOncology podcast, the first of 2026, we bring you key updates in the use of artificial intelligence (AI) in oncology and how it will impact clinicians and patients alike. Join renowned experts Anita Grigoriadis, PhD, King’s College London, London, UK, Rosalind Picard, ScD, MIT Media Lab, Cambridge, MA, Jana Lipkova, PhD, University of California, Irvine, CA, and Roberto Salgado, M
Highlights from SABCS 2025
In this episode of the VJOncology Podcast, we bring you key highlights from the San Antonio Breast Cancer Symposium 2025 (SABCS 2025). This curated episode features expert insights into practice-changing data across HER2-positive metastatic disease, hormone receptor–positive early breast cancer, and the growing role of artificial intelligence in risk stratification. Leading investigators discuss a
Updates in GU cancer at ESMO 2025: SunRISe-4, PSMAddition, and more
In this week’s VJOncology podcast, we will be covering highlights from ESMO 2025 in Berlin, Germany. Gain expert insights in the field of genitourinary cancers, including highly-anticipated trial results, emerging biomarkers in kidney cancer, and the evolving role of radionuclides in prostate cancer. Join renowned speakers Andrea Necchi, MD, IRCCS San Raffaele Hospital and Scientific Institute, M
GI cancer highlights at ESMO 2025: FORTITUDE-101, STELLAR-303, and more
In this week’s VJOncology podcast, we have the pleasure to bring you key updates in gastrointestinal cancer at ESMO 2025, which we attended live in Berlin. Join esteemed experts Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, Michele Reni, MD, IRCCS San Raffaele Scientific Institute, Milan, Italy, Stephen Lam Chan, MD, FRCP, Chinese University of Hong Kong, Hong Kong, Chin
Lung cancer at ESMO 2025: new targets, biomarkers & the changing landscape
In this episode of the VJOncology Podcast, we bring you four standout interviews from ESMO 2025 that are reshaping the way we think about lung cancer. From antibody-drug conjugates and bispecific T-cell engagers through novel HER2-targeted TKIs to tumour-immune microenvironment biomarkers, the treatment paradigm is evolving rapidly.
Join us as we explore findings from the Phase III OptiTROP-Lung04
ESSO 44: the latest updates in surgical oncology
In this week’s podcast from VJOncology, leading experts share key insights from the 44th Congress of the European Society of Surgical Oncology (ESSO 44), held in Gothenburg, Sweden. The meeting brought together global specialists to discuss innovations in cancer surgery, including artificial intelligence, robotics, and fluorescence imaging.
Beate Rau, MD, PhD, highlights advances across gastrointe
Breast Cancer Awareness Month - the evolving role of ADCs
In this week’s VJOncology podcast, leading experts share the latest updates in ADCs in HER2-positive and metastatic breast cancer in recognition of Breast Cancer Awareness Month.
Charles Geyer, MD, discusses pivotal results from the Phase III DESTINY-Breast05 trial, where trastuzumab deruxtecan (T-DXd) significantly improved invasive disease-free and disease-free survival versus trastuzumab emtans
Highlights from ESMO 2025
In this week’s VJOncology podcast, leading experts share key updates presented at the ESMO 2025 Congress in Berlin, Germany.
Sara Tolaney, MD, MPH, highlights the expanding role of ADCs in earlier lines of metastatic breast cancer, presenting data from the DESTINY-Breast09 and ASCENT-03 trials, and discusses results from DESTINY-Breast05, where trastuzumab deruxtecan demonstrated superior outcomes
Liver cancer awareness month: evolving strategies in immunotherapy and targeted treatment
In this week’s VJOncology podcast, leading experts share the latest updates in the management of hepatocellular carcinoma (HCC) in recognition of Liver Cancer Awareness Month.
Stephen Lam Chan, MD, FRCP, discusses emerging immunotherapy and targeted approaches, including novel TIM3 and TIGIT inhibitors, and findings from the SIERRA study of durvalumab and tremelimumab in advanced HCC. Lorenza Rima
Challenges and opportunities in cerebrospinal fluid liquid biopsies in brain tumors
In this week’s VJOncology podcast, we are joined by brain tumor experts Stephen Bagley, MD, MSCE, University of Pennsylvania, Philadelphia, PA, and Cecile Riviere-Cazaux, PhD, Mayo Clinic, Rochester, MN, as they discuss the latest updates in cerebrospinal fluid (CSF) liquid biopsies in brain tumors. They will comment on the rationale and challenges in CSF liquid biopsies in this space, current res
From cold tumors to hot targets: immunotherapy advances in sarcoma treatment
In this week’s exclusive VJOncology podcast, we are joined by Javier Martín-Broto, MD, PhD, Fundación Jiménez Díaz University Hospital, Madrid, Spain, who shares expert insights on the evolving role of immunotherapy in sarcoma. He discusses the unique immunosensitivity of alveolar soft part sarcoma, the potential of combining checkpoint inhibitors with anti-angiogenic or anti-CTLA-4 agents, and en
WCLC 2025 highlights: FLAURA2, HARMONi, and more
In this week’s VJOncology podcast, we have the pleasure to bring you key updates in lung cancer at IASLC 2025 World Conference on Lung Cancer (WCLC), which we attended live in Barcelona, Spain. Join experts John Varlotto, MD, Marshall University, Huntington, WV, Alessio Cortellini, MD, Bio-Medico University, Rome, Italy, Ana Baramidze, MD, PhD, Todua Clinic, Tbilisi, Georgia, Nicolas Girard, MD, I
Precision medicine in head & neck cancer: the rise of ADCs and targeted agents
In this week’s podcast from VJOncology, three leading experts provide insights into the latest advances in precision medicine for head and neck cancer.
Luigi Lorini of Humanitas Research Hospital discusses the evolving treatment landscape of immunotherapy in head and neck squamous cell carcinoma. Danny Rischin of the Peter MacCallum Cancer Centre presents findings from a Phase II trial evaluating
Therapeutic options beyond ADCs in HER+ breast cancer
In this week’s VJOncology podcast, we will be joined by Rupert Bartsch, MD, Medical University of Vienna, Vienna, Austria, as he outlines current and emerging strategies for managing HER2-positive metastatic breast cancer after antibody–drug conjugate (ADC) therapy, with a focus on trastuzumab deruxtecan (T-DXd). He discusses the use of tucatinib-based regimens, mechanisms of resistance to agents
AI in Oncology: From Detection to Treatment
In this week’s installment of the VJOncology podcast, we will examine the cutting-edge applications of artificial intelligence in clinical oncology. This episode presents a curated series of expert insights into AI-driven tools for early detection, diagnostic precision, biomarker development, treatment guidance, and prognostic assessment. Leading clinicians and researchers discuss breast, sarcoma,
GI cancer highlights from ASCO 2025 with J. Randolph Hecht, Jasmine Mitchell and Jingran Ji
Join leading GI cancer experts J. Randolph Hecht, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, Jasmine Mitchell, UCLA Santa Monica Medical Center, Santa Monica, CA, and Jingran Ji, UCLA Santa Monica Medical Center, Santa Monica, CA, as they share key insights from the most impactful gastrointestinal cancer updates presented at ASCO 2025.
In this episode, they discuss pivotal trials i
Highlights in GU cancer at ASCO 2025
In this week's VJOncology podcast, we will be covering highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting 2025 in Chicago, IL. Gain expert insight on exploratory biomarkers, treatment landscape shifts, and practice-changing trials from leading researchers in the field of genitourinary cancers.
Join renowned speakers Angela Jia, Tian Zhang, Michael Harrison, Margaret Ga
Evolving strategies in gynecologic cancer care
In this episode of the VJOncology podcast, we explore the evolving landscape of gynecologic cancer care with expert insights recorded at the 2025 ESMO Gynaecological Cancers Congress in Vienna. Ilana Cass, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, discusses new data from the RUBY trial and the impact of dostarlimab in endometrial cancer. Christina Fotopoulou, MD, PhD, Imperial College L
Sarcoma awareness month: advances in precision medicine
In this weeks podcast from VJOncology, five leading experts share updates and insights on the evolving landscape of precision medicine in sarcoma.
Robin Jones discusses the complexities of implementing precision medicine and presents results from a Phase III trial of catequentinib in advanced leiomyosarcoma. Javier Martín-Broto explores recent advances in immunotherapy and shares findings from Coh
CAR-T and cellular therapy updates in brain tumors
In this weeks VJOncology podcast, we have the pleasure to bring you key updates in CAR-T and cellular therapies in brain tumors. Gain expert insights on landmark trials, treatment advances, and shifting screening practices from some of the foremost voices in the field. Topics of discussion include a Phase I trial of intracranial B7H3-directed CAR-T cell therapy in patients with recurrent glioblast
Breakthrough advances from ESMO GI 2025
This week’s VJOncology podcast episode highlights four breakthrough studies from ESMO GI 2025 in Barcelona, Spain, featuring expert insights on gastrointestinal cancer advances. Coverage includes the EXPEL PANC study combining BXCL701 with pembrolizumab for pancreatic cancer, SIERRA study safety data on the STRIDE regimen for hepatocellular carcinoma, TALENTACE trial results combining TACE with at
Lung cancer highlights from ASCO 2025 with Joao Victor Alessi and Alessandro Di Federico
Join esteemed experts Joao Victor Alessi, Hospital Sírio-Libanês, Sao Paolo, Brazil, and Alessandro Di Federico, Dana-Farber Cancer Institute, Boston, MA, as they discuss the most anticipated updates in lung cancer presented at ASCO 2025, as they comment on ground-breaking trials and provide their insights on the significance of the findings and updates.
In this episode, they comment on the potent
Breast Cancer highlights from ASCO 2025 with Kevin Kalinsky and Komal Jhaveri
Join our experts as they delve into the latest advancements in breast cancer presented at ASCO 2025, as they comment on highly anticipated trials and gives their perspectives on the significance of the findings and updates.
In this episode, Kevin Kalinsky, Emory University Hospital, Atlanta, GA, and Komal Jhaveri, Memorial Sloan Kettering Cancer Center, New York, NY, receive updates on trials pres
Gynecological cancer updates at ASCO 2025
In this weeks VJOncology podcast, we have the pleasure to bring you key updates in gynecological cancer from ASCO 2025, which we attended live in Chicago, IL. Join leading experts as they comment on key trials and provide their insights on the ever-evolving treatment landscape and screening patterns.
Dr Jyoti Mayadev gives an overview of highly anticipated trials at the conference including the
Breakthrough advances from ASCO 2025
In this ASCO 2025 edition of VJOncology podcasts, we spotlight five game-changing studies set to reshape cancer care across multiple tumor types.
Join our host and a panel of leading oncology experts as they unpack the most impactful data from this year’s American Society of Clinical Oncology Annual Meeting. Discover pivotal insights from the MATTERHORN trial in gastric cancer, explore KRAS G12C-t
VJOncoAlert Journal Club
In this week’s podcast, we take you through the latest episodes of the VJOncoAlert Journal Club—a collaborative series from VJOncology and OncoAlert that brings together leading oncology experts to discuss the most impactful and practice-changing research in the field.
We are joined by Misty Shields, MD, PhD, from the Indiana University Simon Comprehensive Cancer Center in Indianapolis, IN, who di
Adjuvant Therapy for Hepatocellular Carcinoma
Welcome to this week's podcast by VJOncology, where we delve into the latest developments in adjuvant therapy for hepatocellular carcinoma. Join five leading experts as they discuss cutting-edge research and its impact on clinical practices.
Stephen Chan, MBBS, MRCP, The Chinese University of Hong Kong, Hong Kong, China, Laura Williams Goff, MD, MSCI, MMHC, Vanderbilt-Ingram Cancer Center, Nashvil
Prostate cancer awareness month: advances in liquid biopsies
In this week's VJOncology podcast, we are focusing again on Prostate Cancer Awareness Month, where we have collaborated with experts on liquid biopsies for tracking and predicting treatment outcomes in metastatic castration-resistant prostate cancer.
Join Chinmay Jani from the Sylvester Comprehensive Cancer Centre, Xin Gao from Massachusetts General Hospital Cancer Center, Christos Kyriakopoulos f
BTOG 2025 highlights
In this weeks VJOncology podcast, we explore key update from BTOG 2025 in thoracic oncology.
Prof. Sanjay Popat discusses the evolving role of ADCs in lung cancer treatment, focusing on efficacy, toxicity management, and biomarker integration. Prof. Samreen Ahmed examines ADC resistance mechanisms, drawing insights from breast cancer therapy to refine drug development strategies. Prof. Robert Rint
Liquid biopsy in breast cancer
In this weeks VJOncology podcast, three oncology experts delve into the transformative potential of liquid biopsy in breast cancer treatment.
First, Michail Ignatiadis (Jules Bordet Institute, Brussels, Belgium) discusses the clinical applications and challenges of utilizing liquid biopsy in metastatic breast cancer, focusing on the Phase III TREAT ctDNA trial (NCT05512364) and its implications
Prostate cancer awareness month: developments in radioligand therapy
In this podcast, we will discuss recent developments in radioligand therapy for metastatic castration-resistant prostate cancer (mCRPC) treatment, as part one of our series for Prostate Cancer Awareness Month. Listen to leading experts as they share breakthroughs in mCRPC research.
First, Omid Yazdanpanah, MD, from the University of California, shares findings from the VISION trial, which assess
Key updates at ASCO GU 2025: STAMPEDE, CheckMate 214, and more
Join us in this episode as we go through the latest advancements in genitourinary cancer treatment presented at ASCO GU 2025 in San Francisco. Our expert guests provide insights into ground-breaking trials and studies that are reshaping the landscape of cancer therapy.
Join Nadine Houede, Xinan Sheng, Nicholas James, and Wenxin Xu, as they discuss highly anticipated updates such as results of neoa
Cellular therapies in solid tumors
Welcome to this week's podcast by VJOncology, where we delve into the emerging trends and challenges in the field of cellular therapies for oncology. Our expert panel includes Leonardo Ferreira (The Medical University of South Carolina, Charleston, SC), who discusses the groundbreaking potential and current obstacles of CAR T cells in treating solid tumors, emphasizing the innovative role of chime
Therapeutic options for PD1 refractory skin cancer
In this podcast, we explore the latest advancements in the treatment of PD-1 refractory melanoma. This week, we are joined by Allison Betof Warner (Stanford Cancer Center, Stanford, CA) and Omid Hamid (The Angeles Clinic and Research Institute, Los Angeles, CA) and Inderjit Mehmi (The Angeles Clinic and Research Institute, Los Angeles, CA).
We will hear about the clinical definitions and significa
Unlocking the Potential of ctDNA in Colorectal Cancer Management
In this week’s podcast, we will provide updates the emerging roles of circulating tumor DNA (ctDNA) in managing colorectal cancer. We are joined by Michael Brian LaPelusa, MD, University of Texas MD Anderson Cancer Center, Houston, TX; Juan Manuel O’Connor, MD, MSc, Instituto Alexander Fleming, Buenos Aires, Argentina; Anup Kasi, MD, MPH, University of Kansas Cancer Center, Kansas City, KS; Giulia
Breast Cancer Updates from SABCS 2024
In this week’s podcast, we will discuss the most recent developments in breast cancer from the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX. Join us as renowned experts exclusively speak with us on highly anticipated findings from clinical trials across different breast cancer subtypes.
Gaia Griguolo from University of Padova in Italy, first discusses the PATINA tri
Novel immune checkpoint targets beyond PD-1 and CTLA-4 in solid tumors
This week’s podcast from VJOncology brings you the latest updates on novel checkpoint inhibitors that target LAG-3, TIGIT, and TIM3 in solid tumors. Our panel of experts share the latest findings from their clinical trials that tested the efficacy of different immune checkpoint inhibitors in neoplastic tumors.
Myriam Chalabi from the Netherlands Cancer Institute shares results from the NICHE-2 and
Antibody drug conjugates in gastrointestinal cancers
This week’s podcast from VJOncology brings you key updates in antibody drug conjugates (ADCs) for gastrointestinal cancer. Our expert panel discusses the potential of ADCs targeting HER2, CMET, and CEACAM5 in gastric and colorectal cancers.
Hear from experts Kohei Shitara (National Cancer Center Hospital East), Yelena Janjigian (Memorial Sloan Kettering Cancer Center), John Strickler (Duke Cancer
Novel therapeutics in PD-1 refractory melanoma
This week’s podcast from VJOncology explores key advancements in the treatment of PD-1 refractory melanoma. Hear from leading experts, Alison Betoff Warner (Stanford University, Stanford, CA), Andrew Furness (Royal Marsden Hospital, London, UK), Anna Di Giacomo (University Hospital of Siena, Siena, Italy), María Vieito (Vall d’Hebron Institute of Oncology, Barcelona, Spain), and Yana Najjar (UPMC
Climate Change and Other Environmental Factors on Lung Cancer Risk at WCLC 2024
In this week’s podcast, we explore the critical links between environmental factors and lung cancer risk, focusing on the impacts of climate change, pollution, and exposure in conflict zones. Join us as we hear from experts Felipe Roitberg, MD, Brazilian Hospital Services Company (EBSERH), Brasília, Brazil, and Leticia Nogueira, MD, American Cancer Society, Palm Harbor, FL.
They share their insigh
GI updates from ESMO 2024
This week’s podcast from VJOncology brings you key updates in gastrointestinal cancer from the European Society of Medical Oncology (ESMO) 2024 annual meeting, which took place in Barcelona, Spain.
Hear from experts, Jessie Elliot (Trinity St. James’s Cancer Institute), Myriam Chalabi (Netherlands Cancer Institute), and Changhoon Yoo (Asan Medical Center) as they discuss the latest in biliary trac
Updates in the management of refractory colorectal cancer
In this week’s podcast, we bring you the latest developments in the field of refractory colorectal cancer. We are joined by Rocio Garcia-Carbonero, MD, PhD, University Hospital 12 De Octubre, Madrid, Spain; Kathrin Heinrich, MD, Ludwig-Maximilians-Universität München, Munich, Germany; Chiara Cremolini, MD, PhD, University of Pisa, Pisa, Italy; and Cristina Smolenski, MD, Gustave Roussy, Villejuif,
ESSO 43 Highlights
In this podcast, we bring you exclusive insights from the 43rd Congress of the European Society of Surgical Oncology (ESSO 43), held in Antwerp, Belgium. We will be joined by Isabel Rubio, MD, PhD (Vall d'Hebron University Hospital, Barcelona, Spain), who discusses the dual focus of modern cancer surgery and the transformative impact of robotic surgery; Sylvie Bonvalot, MD, PhD, HDR (Institut Curi
Highlights from ESMO 2024
In this week’s podcast, we bring you updates from the ESMO 2024 Congress in Barcelona, featuring expert discussions on cutting-edge oncology research. We are joined by Peter Schmid, FRCP, MD, PhD, Barts Cancer Institute, London, UK; Minke Lukas, MD, Netherlands Cancer Institute, Amsterdam; Guru Sonpavde, MD, AdventHealth Cancer Institute, Orlando, FL; Sanjay Popat, MBBS, FRCP, PhD, The Royal Marsd
Latest updates in managing brain metastases
In this podcast, we bring you the latest insights into managing brain metastases, with expert commentary from Manesh Mehta, MD, Miami Cancer Institute, Miami, FL; Sunandana Chandra, MD, MS, Northwestern University, Chicago, IL; Gaia Griguolo, MD, University of Padova, Padova, Italy; Orit Kaidar-Person, MD, Sheba Medical Center, Ramat Gan, Israel; and Janice Wing-Hang Tsang, MBBS, MRCP, FRCP, Unive
Updates in immunotherapy for GU cancer
In this podcast, we highlight some of the latest updates in the use of immunotherapy to treat genitourinary cancer. This week we will be joined by Camillo Porta, MD, University of Bari Aldo Moro, Bari, Italy, Joaquim Bellmunt, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, Arlene Siefker-Radtke, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, and Maria Bourlon, MD, MS, El
Advancements in precision medicine for colorectal cancer
In this week's podcast, we will be covering recent updates and integrating precision medicine for the treatment of colorectal cancer. We'll be covering a wide range of topics including biomarker-driven treatments, challenges in using minimal residual disease in the clinic and more.
Listen to expert insights from Scott Kopetz, The University of Texas MD Anderson Cancer Center, Houston, TX, Giulia M
iwCAR-T sessions: clinical advances in GI cancers
In this podcast, we join leading experts Randy Hecht from UCLA, Diane Simeone from University of California San Diego, and Ben Schechter from Dana-Farber Cancer Institute as they delve into groundbreaking advancements in GI cancer therapies, as presented at the latest iwCAR-T workshop in Miami, Florida.
Explore the latest updates and insights on translational research in pancreatic cancer, includi
iwCAR-T sessions: cell therapies for melanoma and sarcomas
In this week’s podcast, we join experts Allison Betof Warner from Stanford Medicine, Amod Sarnaik from Moffitt Cancer Center, and Elizabeth Loggers from Fred Hutchinson Cancer Center on transformative innovations in cell therapies for melanoma and sarcomas, as presented at the most recent iwCAR-T workshop in Miami, Florida.
Discover the latest updates and perspectives on advanced TIL therapies, in
iwCAR-T sessions: Advances in breast and gynecological cancers
In this week's episode, we join Jennifer Specht from Fred Hutchinson Cancer Center, Saurabh Garg from Moffitt Cancer Center, and Rizwan Romee from Dana-Farber Cancer Institute on pioneering advancements in CAR-T cell therapies for breast and gynecological cancers, as discussed at the recent 6th annual iwCAR-T workshop in Miami, Florida.
Tune in to learn about the fascinating evolution of ROR1-targ
iwCAR-T sessions: CAR-T clinical advances in lung cancer
Welcome to another episode of VJOncology! In this episode, we dive into cutting-edge CAR-T cell therapies for the management of lung cancers, discussed at the sixth International Workshop on CAR-T in Miami, Florida.
Join Julian Molina from the Mayo Clinic, Ben Creelan from Moffitt Cancer Center, and Adam Schoenfeld from Memorial Sloan Kettering Cancer Center as they explore innovative CAR-T strate
Highlights in colorectal cancer at ASCO and ESMO GI 2024
In this week’s podcast, we will discuss the most recent developments in colorectal cancer from the 2024 ASCO and ESMO Gastrointestinal (GI) Annual Meetings held in Chicago, IL and Munich, Germany respectively. Join us as five renowned experts discuss highly anticipated findings from clinical trials across different colorectal cancer subtypes.
Heinz-Josef Lenz from the University of Southern Califo
Skin Cancer Highlights at ASCO 2024
Welcome to another episode of VJ Oncology Podcasts! Today, we spotlight key advances in skin cancer research shared at ASCO 2024. Join us as six leading experts reveal groundbreaking findings from recent clinical trials.
First, Georgina Long from the University of Sydney discusses the NADINA trial, a landmark Phase III study on neoadjuvant immunotherapy for melanoma. Next, Omid Hamid from The Ange
iwCAR-T sessions: Clinical Advances in Head and Neck Cancer and Brain Tumors
Welcome to another episode of VJ Oncology! In this episode, we delve into pioneering CAR-T strategies for head and neck cancers and brain tumors, as discussed at the recent iwCAR-T workshop in Miami, Florida.
Join Kedar Khartani from Moffitt Cancer Center and Susanna Baumeister from Dana-Farber Cancer Institute as they explore groundbreaking CAR-T approaches and clinical trials targeting glioblast
ELCC 2024 highlights
This week, we bring you key highlights from European Lung Cancer Congress (ELCC) 2024
which took place in Prague, Czech Republic, including the EVOKE-02, IMscin002,
FLAURA2, MARIPOSA-2 and PAPILLON clinical trials. Hear from Federico Cappuzzo, AUSL
della Romagna-Ravenna, Ravenna, Italy, Natalia Valdiviezo, Instituto Nacional de
Enfermedades Neoplásicas, Lima, Peru, Alexander Spira, Next Oncology
Key Updates from ESMO Breast 2024
In today's episode, we bring you key highlights from ESMO Breast 2024, diving into important discussions surrounding the latest research and clinical data regarding breast cancer. We bring insights from top field experts, set to enlighten you on new breakthroughs and developments, including updates from the DESTINY-Breast02 trial as well as first-line CDK4/6 inhibitor clinical data in HR+/HER2-adv
